We are live on ! Find out more
EVH icon

Evolent Health

167 hedge funds and large institutions have $1.57B invested in Evolent Health in 2017 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 64 increasing their positions, 42 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

257% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 14

71% more capital invested

Capital invested by funds: $921M → $1.57B (+$650M)

52% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 42

50% more call options, than puts

Call options by funds: $3.93M | Put options by funds: $2.62M

27% more funds holding

Funds holding: 131167 (+36)

21.23% more ownership

Funds ownership: 78.85%100.08% (+21%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
167
Holders Change
+36
Holders Change %
+27.48%
% of All Funds
4.16%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
50
Increased
64
Reduced
42
Closed
14
Calls
$3.93M
Puts
$2.62M
Net Calls
+$1.31M
Net Calls Change
-$3.37M
Name Holding Trade Value Shares
Change
Change in
Stake
IIA
176
IPG Investment Advisors
California
-$206K -9,250 Closed
FPF
177
FNY Partners Fund
New York
-$22K -1,000 Closed
TDC
178
Thompson Davis & Co
Virginia
-$20K -875 Closed
QT
179
Quantbot Technologies
New York
-$18K -831 Closed
SF
180
Synovus Financial
Georgia
-$3K -150 Closed
IA
181
IFP Advisors
Florida
+$216 +9 New

EVH Hedge Fund Activity: Q2 2017 in Review

167 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q2 2017, worth a combined $1.57B — up 71% from $921M a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new EVH positions and 14 closed out — a net gain of 36 holders — while 64 added to existing stakes and 42 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $128M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $28.7M.

  • 167 institutional investors held Evolent Health (EVH) as of Q2 2017, up from 131 in Q1 2017.
  • Funds reported $1.57B of Evolent Health stock for Q2 2017, up 71% quarter-over-quarter.
  • 50 funds opened new Evolent Health positions in Q2 2017 and 14 closed out, a net change of +36 holders.
  • The largest Evolent Health buyer in Q2 2017 was Fidelity Investments, an estimated $128M added.
  • The largest Evolent Health seller in Q2 2017 was TPG Group Holdings (SBS) Advisors, an estimated $28.7M sold.

Based on aggregated 13F filings for Q2 2017.